On Wednesday, the Food and Drug Administration approved a treatment that genetically modifies a patient’s own blood cells in order to attack childhood leukemia, a landmark decision opens the door for an era of FDA-sanctioned human gene modification.
Source: Gizmodo – The FDA Just Approved the First ‘Living’ Therapy to Treat Childhood Leukemia